Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Heart Rhythm Center
Phoenix, Arizona, United States
- Usc Los Angeles - Keck Hopsital
Los Angeles, California, United States
- San Diego Cardiac Center
San Diego, California, United States
- University of Colorado School of Medicince, Denver
Denver, Colorado, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Kumc Research Institute
Kansas City, Kansas, United States
- St. Luke'S Hospital Duluth
Duluth, Minnesota, United States
- Texas Cardiac Arrythmia Research Foundation
Austin, Texas, United States
- Bcm/chi St. Luke'S Hospital
Houston, Texas, United States
- Houston Methodist
Houston, Texas, United States
- Houston Vamc
Houston, Texas, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 31 Dec 2019
- Completion
- 31 Dec 2019
- Last update posted
- 21 Aug 2025
- Registered enrollment
- 343
- Registry id
- NCT01898221
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.